|
|
Security
Type |
|
Security
Class Title |
|
Fee
Calculation or Carry Forward Rule |
|
|
Amount
Registered(1) |
|
|
Proposed
Maximum Offering Price Per Unit(2)
|
|
Maximum
Aggregate Offering Price(2) |
|
|
Fee Rate
|
|
Amount of
Registration Fee |
|
|
|||||||||
Fees to Be Paid
|
|
Equity
|
|
Ordinary shares, par value of NIS 0.0000769
|
|
|
Rule 457(c)
|
|
|
|
16,500,894(3)
|
|
|
$
|
0.84
|
|
|
$
|
13,860,751
|
|
|
$147.60 per $1,000,000
|
|
|
$
|
2,045.85
|
||||
Fees Previously Paid
|
||||||||||||||||||||||||||||||
|
|
Total Offering Amounts
|
|
|
|
|
|
|
|
|
|
|
$
|
13,860,751
|
|
|
$
|
12,045.85
|
||||||||||||
Total Fees Previously Paid
|
—
|
|||||||||||||||||||||||||||||
|
|
Total Fee Offsets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
||||||||
|
|
Net Fee Due
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,045.85
|
(1) |
Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities
Act”), this registration statement shall also cover any additional ordinary shares, par value of NIS 0.0000769 (“ordinary shares”), of
Entera Bio Ltd., that may be offered or become issuable by reason of any share dividend, share split, recapitalization or other similar transaction effected
without the receipt of consideration which results in an increase in the number of outstanding ordinary shares.
|
(2) |
Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(c) under the Securities Act and based upon the average of the high and
low sales prices of an ordinary share as reported on the Nasdaq Capital Market on January 31, 2024.
|
(3) |
Representing 16,500,894 ordinary shares, including 9,838,505 ordinary shares issuable upon exercise of certain issued and outstanding warrants.
|